You just read:

CytRx to Present Global Phase 3 Aldoxorubicin Clinical Data in Patients with Soft Tissue Sarcomas at the 2017 American Society of Clinical Oncology Annual Meeting

News provided by

CytRx Corporation

May 17, 2017, 17:04 ET